New York, US–Mar 20, 2019 Creative Biolabs, an outstanding custom service supplier in recombinant antibody discovery and manufacturing, has managed to upgrade its library construction and screening processes, capable of providing the most comprehensive list of Hi-Affi™ recombinant antibody products around the world. Moreover, its high-throughput antibody production service ensures the efficient manufacturing of top-quality antibodies.
The recombinant antibody (rAb) is an antibody produced by means of the recombinant DNA technology, which involves the insert of a DNA fragment into the bacterial, yeast, or mammalian cells. Compared with the monoclonal antibodies, the recombinant antibodies (rAbs) come with rather high specificity yet low immunogenicity. Given these appealing advantages, Creative Biolabs has optimized its Hi-Affi™ rAb service to supply the supreme rAb products to its customers. Thus far, its rAbs have been well applied to medical research for the treatment of a host of diseases.
“Of late, we succeeded in upgrading our library construction and screening processes to manufacture Hi-Affi™ rAbs. With this improvement, our company promises to isolate clones in a short period, while making sure of the high affinity at a sub-nanomolar level. Besides, bulk order from 1mg to 10g has thus been made available, as well. Most importantly, our rAb has many other advantages, such as high purity of beyond 98%, broad applications, reproducibility, complete condition control, non-involvement of animals, and use of engineering technology, etc,” said a scientist from Creative Biolabs.
With regard to antibody production, the High-throughput Antibody Production Service from this company takes advantage of the most up-to-date technologies associated with high-throughput antibody production. The service makes it possible to perform antibody expression in ample quantities in various eukaryotic and prokaryotic hosts. It’s worth mention that a considerable number of antibodies produced and purified by this service have been made use of for demanding drug screening and development.
“By adopting the advanced gene synthesis and transient expression technologies, we have screened and produced numerous target antibodies with striking bioactivities. Our antibody production service satisfies the market demands for higher throughput. With this service, screening and producing can be finished within four weeks starting from the antibody sequencing, Thereafter, the desired antibody products can be available in only two weeks. Frankly speaking, this is a truly attracting service about antibody production,” the same scientist from Creative Biolabs added.
The medical science is developing so fast that in the near future the world may as well see much more significant progress in the improvement of rAbs, whether in terms of their quality or productivity. Undoubtedly, this improvement will lead to the production of more high-quality rAb products, so as to fulfill the increasingly diverse market demands.
About Creative Biolabs
As a leader in recombinant antibody discovery and manufacturing, Creative Biolabs is committed to providing its global customers with the most comprehensive range of recombinant antibody products and extensive service portfolio at the most competitive price. Its products range from antibody/peptide libraries, biosimilar cell lines, chimeric antigen receptor (CDR) products, antibody-drug conjugates (ADC) to engineered antibodies. It also provides a variety of custom antibody discovery and engineering services.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-619-7922Address:45-1 Ramsey Road City: ShirleyState: New YorkCountry: United StatesWebsite: www.creativebiolabs.net/
